Valuation: Profarma Distribuidora de Produtos Farmacêuticos S.A.

Market Cap 1.13B 222M 198M 184M 167M 315M 21.11B 321M 2.21B 864M 10.98B 833M 816M 35.08B P/E 2024
6.95x
P/E 2025 9.42x
Enterprise Value 2.3B 451M 402M 373M 340M 640M 42.87B 652M 4.49B 1.76B 22.3B 1.69B 1.66B 71.25B EV / Sales 2024
0.18x
EV / Sales 2025 0.2x
Free-Float
32.86%
Yield 2024
8.86%
Yield 2025 -
07-30 Profarma Distribuidora de Produtos Farmacêuticos S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 CI
05-07 Profarma Distribuidora de Produtos Farmacêuticos S.A. Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
03-15 Profarma Distribuidora de Produtos Farmacêuticos S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2025 CI
03-03 Brazil's Profarma to buy 4Bio from Raia Drogasil in 600 mln reais deal RE
11-05 Bmk, Bpl negotiate potential acquisition of Bpl shares in Brazil's Profarma RE
30/10/25 Profarma Distribuidora de Produtos Farmacêuticos S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 CI
31/07/25 Profarma Distribuidora de Produtos Farmacêuticos S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 CI
04/05/25 Profarma Distribuidora de Produtos Farmacêuticos S.A. Reports Earnings Results for the First Quarter Ended March 31, 2025 CI
18/03/25 Profarma Distribuidora de Produtos Farmacêuticos S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2024 CI
18/03/25 Profarma Distribuidora de Produtos Farmacêuticos S.A. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2024 CI
31/10/24 Profarma Distribuidora de Produtos Farmacêuticos S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 CI
06/08/24 Profarma Distribuidora de Produtos Farmacêuticos S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024 CI
07/05/24 Profarma Distribuidora de Produtos Farmacêuticos S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
1 day+30.37%
1 week+1.88%
Current month+24.56%
1 month+21.29%
3 months+36.54%
6 months+14.37%
Current year+1.10%
1 week 8.79
Extreme 8.79
9.42
1 month 7
Extreme 7
9.42
Current year 6.11
Extreme 6.11
9.7
1 year 6.11
Extreme 6.11
9.7
3 years 3.4
Extreme 3.4
9.7
5 years 2.92
Extreme 2.92
9.7
10 years 2.87
Extreme 2.87
11.79
Manager TitleAgeSince
Chief Executive Officer 58 20/04/2010
Director of Finance/CFO 68 31/12/1992
Director TitleAgeSince
Chairman 58 02/04/2008
Director/Board Member 91 20/04/2010
Director/Board Member 62 20/04/2010
Date Insider Type Main position Quantity % Market Cap. Importance
08/08/25 Others 1 0.0000% -
09/12/24 Sell 12,200 0.0099%
09/12/24 Sell 12,400 0.0100%
Change 5-day change 1-year change 3-year change Capi.($)
+30.37%+1.88%+30.55%+147.45% 225M
+3.55%+5.29%+54.07%+105.45% 1,077B
-0.25%-2.00%+32.71%+61.48% 612B
+0.59%+4.44%+23.69%+91.54% 501B
-1.48%+1.68%+71.42%+39.59% 364B
+2.37%+5.47%+32.67%+48.87% 353B
+2.64%+4.90%+21.01%+43.85% 278B
+3.24%+4.25%-0.31%+15.71% 251B
+1.86%+5.07%+47.70%+52.77% 230B
+2.49%+7.16%+32.82%+102.67% 190B
Average +4.50%+2.19%+34.63%+70.94% 385.67B
Weighted average by Cap. +1.05%+1.58%+39.06%+71.72%

Financials

2024 2025
Net sales 10.15B 1.99B 1.78B 1.65B 1.5B 2.83B 189B 2.88B 19.82B 7.75B 98.52B 7.48B 7.32B 315B 11.45B 2.25B 2B 1.86B 1.69B 3.19B 214B 3.25B 22.35B 8.75B 111B 8.43B 8.25B 355B
Net income 115M 22.48M 20.03M 18.59M 16.95M 31.89M 2.14B 32.49M 224M 87.51M 1.11B 84.36M 82.59M 3.55B 119M 23.33M 20.79M 19.29M 17.59M 33.09M 2.22B 33.72M 232M 90.81M 1.15B 87.54M 85.7M 3.69B
Net Debt 1.02B 200M 178M 165M 150M 283M 18.97B 288M 1.99B 777M 9.87B 749M 733M 31.53B 1.17B 229M 204M 189M 173M 325M 21.76B 331M 2.28B 891M 11.32B 859M 841M 36.16B
Projected Income Statement - Annual - Profarma Distribuidora de Produtos Farmacêuticos S.A.
Logo Profarma Distribuidora de Produtos Farmacêuticos S.A.
Profarma Distribuidora de Produtos Farmaceuticos SA is a Brazil-based company primarily engaged in the wholesale trading of drugs. The Company's activities are divided into two segments: Pharmaceutical Distribution and Retail. The Pharmaceutical Distribution division is responsible for the wholesale of medicines and personal care and beauty products to pharmaceutical retailers. The Retail division focuses on the management of a pharmacies network under a number of brand names, such as Drogasmil and Tamoio. Its products range includes prescription drugs, over-the-counter (OTC) generics, personal hygiene articles and cosmetics, vaccines, dermatological products and hospital pharmaceuticals, among others. The Company's subsidiaries include Farmadacta Informatica Ltda, Promovendas Representacoes Ltda, Interagile Propaganda e Promocoes Ltda and Locafarma Solucoes de Transportes e Logistica Ltda, among others.
Employees
7,077
Date Price Change Volume
14/10/26 R$9.230 +1.99% 225,500
13/10/26 R$9.050 +0.22% 213,900
09/10/26 R$9.030 -0.33% 391,800
08/10/26 R$9.060 +2.26% 270,800
07/10/26 R$8.860 -0.89% 283,500
  1. Stock Market
  2. Stocks
  3. PFRM3 Stock